Location： Home -Breaking News-Main Text

Cannabis Concept Stocks Surge, Fu'an Pharmaceutical Rises 15%, Lehua Biological Hits 10% Ceiling, Morning Light Biological Rises Over 6%! Trump Considers Reclassifying Cannabis as a Less Hazardous Drug

Breaking News 3 months ago 1.1k
　　Hexun.com August 12th｜Cannabis concept stocks in the A-share market surged collectively, with Fu\'an Pharmaceutical (300194) rising 15%, Lehua Biological (002166) hitting 10% ceiling, and Morning

　　Hexun.com August 12th｜Cannabis concept stocks in the A-share market surged collectively, with Fu'an Pharmaceutical (300194) rising 15%, Lehua Biological (002166) hitting 10% ceiling, and Morning Light Biological (300138) rising over 6%, Dezhao Health (000813) rising over 4%, and Shunao Shares (002565) and Kang'enbei (600572) rising over 3%.

Cannabis Concept Stocks Surge, Fu\'an Pharmaceutical Rises 15%, Lehua Biological Hits 10% Ceiling, Morning Light Biological Rises Over 6%! Trump Considers Reclassifying Cannabis as a Less Hazardous Drug

 

　　According to sources, on August 8th, Washington Post reported that Trump told attendees at a fundraising dinner in New Jersey earlier this month that he intends to reclassify cannabis as a less hazardous drug. Attendees included Kim Rivers, CEO of Trulieve, who encouraged Trump to push for the reform and expand medical cannabis research. Trulieve is one of the largest cannabis companies based in Florida.

　　Attendees at the event said that this adjustment would greatly simplify the process of buying and selling cannabis, making this multi-billion-dollar industry more profitable.

anPharmaceutical(1)cannabis(1)DezhaoHealth(1)enbei(1)Fu(1)Kang(1)LehuaBiological(1)medicalcannabisresearch(1)MorningLightBiological(1)ShunaoShares(1)Trulieve(1)

Related Articles